Cryo-Cell International, Inc.
CCEL
$3.41
-$0.11-3.13%
AMEX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.59% | -2.26% | -2.99% | -1.42% | 1.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.59% | -2.26% | -2.99% | -1.42% | 1.49% |
| Cost of Revenue | -16.53% | 272.27% | -15.26% | -8.31% | -3.96% |
| Gross Profit | 0.71% | -72.60% | 1.40% | 0.90% | 3.43% |
| SG&A Expenses | 8.05% | -9.34% | -6.88% | 5.98% | 4.74% |
| Depreciation & Amortization | -4.17% | -6.22% | -4.57% | 217.89% | 478.01% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.07% | 44.97% | -11.26% | 1.46% | -1.68% |
| Operating Income | -27.55% | -3,143.50% | 36.74% | -12.17% | 28.59% |
| Income Before Tax | -86.83% | -449.86% | -14.05% | -60.94% | -32.83% |
| Income Tax Expenses | -90.75% | -179.92% | 33.03% | -73.14% | 5.29% |
| Earnings from Continuing Operations | -83.35% | -105.06% | -28.74% | -45.75% | -49.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -83.35% | -105.06% | -28.74% | -45.75% | -49.14% |
| EBIT | -27.55% | -3,143.50% | 36.74% | -12.17% | 28.59% |
| EBITDA | -22.60% | -3,039.07% | 31.05% | -3.80% | 43.72% |
| EPS Basic | -83.43% | -105.33% | -28.68% | -45.54% | -47.92% |
| Normalized Basic EPS | -44.85% | -414.52% | 60.90% | -37.03% | 11.48% |
| EPS Diluted | -80.67% | -105.33% | -30.77% | -50.00% | -55.36% |
| Normalized Diluted EPS | -44.08% | -414.52% | 62.80% | -36.45% | 10.51% |
| Average Basic Shares Outstanding | -0.33% | -0.14% | -0.05% | -0.46% | -2.36% |
| Average Diluted Shares Outstanding | -1.75% | -0.14% | -1.22% | -1.29% | -1.50% |
| Dividend Per Share | -- | -100.00% | -- | -- | -- |
| Payout Ratio | -- | 1.00% | -- | -- | -- |